European Congress of Endocrinology 2024 - Hub sessions

Saturday, 11 May 2024, STOCKHOLM, SWEDEN

Recordings now available: Rhythm-sponsored Hub sessions at ECE 2024

 

Session 1: Sunday 12 May - Rare hypothalamic melanocortin-4 receptor (MC4R) pathway diseases: hyperphagia and early-onset, severe obesity

KEY TOPICS:

  • Overview of MC4R pathway impairments leading to monogenic and syndromic diseas
  • Hyperphagia as a cardinal symptom
  • Challenges in diagnosis and importance of genetic testing, with focus on Bardet-Biedl Syndrome (BBS)

Session 2: Monday 13 May - The role of precision medicine in managing rare MC4R pathway disease, from monogenic obesity to Bardet-Biedl syndrome

KEY TOPICS:

  • Burden of disease and quality of life
  • Clinical experience
  • Multidisciplinary care and the impact of precision medicine

Dr Danilo Fintini provides an overview of MC4R pathway impairments which lead to monogenic and syndromic disease, hyperphagia as well as the challenges in diagnosis and importance of genetic testing for Bardet-Biedl Syndrome (BBS)

Rare hypothalamic melanocortin-4 receptor (MC4R) pathway diseases: hyperphagia and early-onset, severe obesity

Dr Danilo Fintini

Reproducir vídeo

Rhythm Pharmaceuticals utiliza la herramienta de Autenticación de Profesionales Sanitarios de IQVIA para comprobar su elegibilidad para acceder a este contenido audiovisual. Si ya dispone de una cuenta de IQVIA que utiliza con otros profesionales sanitarios, haga clic en 'Iniciar sesión'; de lo contrario, haga clic en 'Registrarse'.

The role of precision medicine in managing rare MC4R pathway disease, from monogenic obesity to Bardet-Biedl syndrome

Prof Giovanni Ceccarini

Reproducir vídeo

Rhythm Pharmaceuticals utiliza la herramienta de Autenticación de Profesionales Sanitarios de IQVIA para comprobar su elegibilidad para acceder a este contenido audiovisual. Si ya dispone de una cuenta de IQVIA que utiliza con otros profesionales sanitarios, haga clic en 'Iniciar sesión'; de lo contrario, haga clic en 'Registrarse'.

Speakers:

Dr Danilo Fintini

(Italy)

Prof Giovanni Ceccarini

(Italy)

If you are interested in hearing more about future Rhythm sponsored events, click here to register your interest.


This meeting was organised and funded by Rhythm Pharmaceuticals and is intended for healthcare professionals only.